These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31086287)

  • 1. The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity.
    Davis JM; Pilon AL; Shenberger J; Breeze JL; Terrin N; Mazela J; Gulczynska E; Lauterbach R; Parad R
    Pediatr Res; 2019 Aug; 86(2):254-260. PubMed ID: 31086287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome.
    Levine CR; Gewolb IH; Allen K; Welch RW; Melby JM; Pollack S; Shaffer T; Pilon AL; Davis JM
    Pediatr Res; 2005 Jul; 58(1):15-21. PubMed ID: 15774846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profiles.
    Shashikant BN; Miller TL; Welch RW; Pilon AL; Shaffer TH; Wolfson MR
    J Appl Physiol (1985); 2005 Dec; 99(6):2204-11. PubMed ID: 16081627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human Clara cell secretory protein treatment increases lung mRNA expression of surfactant proteins and vascular endothelial growth factor in a premature lamb model of respiratory distress syndrome.
    Wolfson MR; Funanage VL; Kirwin SM; Pilon AL; Shashikant BN; Miller TL; Shaffer TH
    Am J Perinatol; 2008 Nov; 25(10):637-45. PubMed ID: 18841530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant Clara cell secretory protein (rhCC10) on inflammatory-related matrix metalloproteinase activity in a preterm lamb model of neonatal respiratory distress.
    Miller TL; Shashikant BN; Pilon AL; Pierce RA; Shaffer TH; Wolfson MR
    Pediatr Crit Care Med; 2007 Jan; 8(1):40-6. PubMed ID: 17149150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC10 reduces inflammation in meconium aspiration syndrome in newborn piglets.
    Angert RM; Pilon AL; Chester D; Davis JM
    Pediatr Res; 2007 Dec; 62(6):684-8. PubMed ID: 17957145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Clara cell 10 (CC10) protein on symptoms and signs of allergic rhinitis.
    Widegren H; Andersson M; Greiff L
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):51-6. PubMed ID: 19205286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Club Cell Protein, CC10, Attenuates Acute Respiratory Distress Syndrome Induced by Smoke Inhalation.
    Lopez E; Fujiwara O; Nelson C; Winn ME; Clayton RS; Cox RA; Hawkins HK; Andersen CR; Wade CE; Hariprakasha H; Prough DS; Pilon AL; Enkhbaatar P
    Shock; 2020 Mar; 53(3):317-326. PubMed ID: 31045988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah V; Ohlsson A; Halliday HL; Dunn MS
    Cochrane Database Syst Rev; 2000; (2):CD001969. PubMed ID: 10796275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CC10 administration to premature infants: in search of the "silver bullet" to prevent lung inflammation.
    Welty SE
    Pediatr Res; 2005 Jul; 58(1):7-9. PubMed ID: 15879298
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury.
    Chandra S; Davis JM; Drexler S; Kowalewska J; Chester D; Koo HC; Pollack S; Welch R; Pilon A; Levine CR
    Pediatr Res; 2003 Oct; 54(4):509-15. PubMed ID: 12815115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of gestation and mechanical ventilation on serum clara cell secretory protein (CC10) concentrations in ventilated and nonventilated newborn infants.
    Loughran-Fowlds A; Oei J; Wang H; Xu H; Wimalasundera N; Egan C; Henry R; Lui K
    Pediatr Res; 2006 Jul; 60(1):103-8. PubMed ID: 16690962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial.
    Kinsella JP; Walsh WF; Bose CL; Gerstmann DR; Labella JJ; Sardesai S; Walsh-Sukys MC; McCaffrey MJ; Cornfield DN; Bhutani VK; Cutter GR; Baier M; Abman SH
    Lancet; 1999 Sep; 354(9184):1061-5. PubMed ID: 10509496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial.
    Askenazi DJ; Heagerty PJ; Schmicker RH; Brophy P; Juul SE; Goldstein SL; Hingorani S;
    J Pediatr; 2021 May; 232():65-72.e7. PubMed ID: 33484699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an intratracheally delivered anti-inflammatory protein (rhCC10) on physiological and lung structural indices in a juvenile model of acute lung injury.
    Miller TL; Shashikant BN; Pilon AL; Pierce RA; Shaffer TH; Wolfson MR
    Biol Neonate; 2006; 89(3):159-70. PubMed ID: 16210850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.